Cargando…

SARS-CoV-2 may trigger inflammasome and pyroptosis in the central nervous system: a mechanistic view of neurotropism

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can enter the central nervous system and cause several neurological manifestations. Data from cerebrospinal fluid analyses and postmortem samples have been shown that SARS-CoV-2 has neuroinvasive properties. Therefore, ongoing studies have...

Descripción completa

Detalles Bibliográficos
Autores principales: Sepehrinezhad, Ali, Gorji, Ali, Sahab Negah, Sajad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8266993/
https://www.ncbi.nlm.nih.gov/pubmed/34241783
http://dx.doi.org/10.1007/s10787-021-00845-4
_version_ 1783720045950533632
author Sepehrinezhad, Ali
Gorji, Ali
Sahab Negah, Sajad
author_facet Sepehrinezhad, Ali
Gorji, Ali
Sahab Negah, Sajad
author_sort Sepehrinezhad, Ali
collection PubMed
description Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can enter the central nervous system and cause several neurological manifestations. Data from cerebrospinal fluid analyses and postmortem samples have been shown that SARS-CoV-2 has neuroinvasive properties. Therefore, ongoing studies have focused on mechanisms involved in neurotropism and neural injuries of SARS-CoV-2. The inflammasome is a part of the innate immune system that is responsible for the secretion and activation of several pro-inflammatory cytokines, such as interleukin-1β, interleukin-6, and interleukin-18. Since cytokine storm has been known as a major mechanism followed by SARS-CoV-2, inflammasome may trigger an inflammatory form of lytic programmed cell death (pyroptosis) following SARS-CoV-2 infection and contribute to associated neurological complications. We reviewed and discussed the possible role of inflammasome and its consequence pyroptosis following coronavirus infections as potential mechanisms of neurotropism by SARS-CoV-2. Further studies, particularly postmortem analysis of brain samples obtained from COVID-19 patients, can shed light on the possible role of the inflammasome in neurotropism of SARS-CoV-2.
format Online
Article
Text
id pubmed-8266993
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-82669932021-07-09 SARS-CoV-2 may trigger inflammasome and pyroptosis in the central nervous system: a mechanistic view of neurotropism Sepehrinezhad, Ali Gorji, Ali Sahab Negah, Sajad Inflammopharmacology Review Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can enter the central nervous system and cause several neurological manifestations. Data from cerebrospinal fluid analyses and postmortem samples have been shown that SARS-CoV-2 has neuroinvasive properties. Therefore, ongoing studies have focused on mechanisms involved in neurotropism and neural injuries of SARS-CoV-2. The inflammasome is a part of the innate immune system that is responsible for the secretion and activation of several pro-inflammatory cytokines, such as interleukin-1β, interleukin-6, and interleukin-18. Since cytokine storm has been known as a major mechanism followed by SARS-CoV-2, inflammasome may trigger an inflammatory form of lytic programmed cell death (pyroptosis) following SARS-CoV-2 infection and contribute to associated neurological complications. We reviewed and discussed the possible role of inflammasome and its consequence pyroptosis following coronavirus infections as potential mechanisms of neurotropism by SARS-CoV-2. Further studies, particularly postmortem analysis of brain samples obtained from COVID-19 patients, can shed light on the possible role of the inflammasome in neurotropism of SARS-CoV-2. Springer International Publishing 2021-07-09 2021 /pmc/articles/PMC8266993/ /pubmed/34241783 http://dx.doi.org/10.1007/s10787-021-00845-4 Text en © The Author(s), under exclusive licence to Springer Nature Switzerland AG 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Review
Sepehrinezhad, Ali
Gorji, Ali
Sahab Negah, Sajad
SARS-CoV-2 may trigger inflammasome and pyroptosis in the central nervous system: a mechanistic view of neurotropism
title SARS-CoV-2 may trigger inflammasome and pyroptosis in the central nervous system: a mechanistic view of neurotropism
title_full SARS-CoV-2 may trigger inflammasome and pyroptosis in the central nervous system: a mechanistic view of neurotropism
title_fullStr SARS-CoV-2 may trigger inflammasome and pyroptosis in the central nervous system: a mechanistic view of neurotropism
title_full_unstemmed SARS-CoV-2 may trigger inflammasome and pyroptosis in the central nervous system: a mechanistic view of neurotropism
title_short SARS-CoV-2 may trigger inflammasome and pyroptosis in the central nervous system: a mechanistic view of neurotropism
title_sort sars-cov-2 may trigger inflammasome and pyroptosis in the central nervous system: a mechanistic view of neurotropism
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8266993/
https://www.ncbi.nlm.nih.gov/pubmed/34241783
http://dx.doi.org/10.1007/s10787-021-00845-4
work_keys_str_mv AT sepehrinezhadali sarscov2maytriggerinflammasomeandpyroptosisinthecentralnervoussystemamechanisticviewofneurotropism
AT gorjiali sarscov2maytriggerinflammasomeandpyroptosisinthecentralnervoussystemamechanisticviewofneurotropism
AT sahabnegahsajad sarscov2maytriggerinflammasomeandpyroptosisinthecentralnervoussystemamechanisticviewofneurotropism